ASCO - Genitourinary Cancers Symposium

Feb 12 from 11:30 AM PST to Feb 14, 2020

Title: “KEYNOTE-046 (Part B): Effects of ADXS-PSA in combination with pembrolizumab on survival in metastatic, castration-resistant prostate cancer patients with or without prior exposure to docetaxel”
Presenter: Dr. Mark N. Stein, Associate Professor, Division of Hematology/Oncology, Columbia University Medical Center
Abstract: 126, Poster number F6
Time: 11:30AM – 1:00 PM, 5:30PM - 6:30 PM PT


San Francisco, California